Jeffrey Ostrove

Jeffrey Ostrove

Chief Executive Officer at Stelios Therapeutics, Inc.

Health Technology
Government
Commercial Services

Profile

Jeffrey M.
Ostrove
is the founder of Magenta Corp.
He currently holds the position of Director at the Biotechnology Innovation Organization, Director at Locanabio, Inc., Director at Paros Bio, Inc., and Chief Executive & Financial Officer, Secretary at Stelios Therapeutics, Inc. Previously, he served as President & Chief Executive Officer at Ceregene, Inc. for a brief period in 2001.
From 2014 to 2016, he was the Chief Executive Officer & Director at AbVitro LLC.
He also held positions as Chief Operating Officer at Medigene, Inc., and as a Principal at both the National Institutes of Health and the National Institute of Allergy & Infectious Diseases.
Dr. Ostrove obtained a doctorate degree from the University of Florida.

Jeffrey Ostrove active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member 2019-05-21
Chief Executive Officer 2016-11-30
Director/Board Member -
All active positions of Jeffrey Ostrove

Former positions of Jeffrey Ostrove

CompaniesPositionEnd
Chief Executive Officer 2015-12-31
National Institute of Allergy & Infectious Diseases Corporate Officer/Principal -
Founder 2010-01-28
Corporate Officer/Principal -
Chief Operating Officer -
See the detail of Jeffrey Ostrove's experience

Training of Jeffrey Ostrove

University of Florida Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Ostrove's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies10

Health Technology

Commercial Services

Health Technology

Health Technology

Government

National Institute of Allergy & Infectious Diseases

Government

Producer Manufacturing

Technology Services

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Jeffrey Ostrove